Cargando…

Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom

Detalles Bibliográficos
Autores principales:	Thomas, W., Varley, J., Johnston, A., Symington, E., Robinson, M., Sheares, K., Lavinio, A., Besser, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182517/ https://www.ncbi.nlm.nih.gov/pubmed/32402996 http://dx.doi.org/10.1016/j.thromres.2020.04.028

Ejemplares similares

Thrombotic complications in critically ill patients with COVID 19
por: Rosen, Raphael J.
Publicado: (2020)

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
por: Siguret, Virginie, et al.
Publicado: (2020)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study
por: Hardy, M., et al.
Publicado: (2023)

The effect of race on composite thrombotic events in patients with COVID-19
por: Esenwa, Charles, et al.
Publicado: (2021)

Delayed catastrophic thrombotic events in post-acute COVID-19
por: Gupta, Abhinav, et al.
Publicado: (2022)

Heparin resistance in COVID-19 patients in the intensive care unit
por: White, D., et al.
Publicado: (2020)

Incidence of thrombotic outcomes for patients hospitalized and discharged after COVID-19 infection
por: Bourguignon, Alex, et al.
Publicado: (2020)

Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit
por: White, D., et al.
Publicado: (2020)

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit
por: Vlot, E.A., et al.
Publicado: (2020)

Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units
por: Doyle, Andrew J., et al.
Publicado: (2020)

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19
por: Porfidia, Angelo, et al.
Publicado: (2022)

Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia()
por: Huang, Ching-Tai, et al.
Publicado: (2021)

Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
por: Godon, Alexandre, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study
por: Rodríguez, Carmen, et al.
Publicado: (2021)

“COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting”: Classification and possible therapeutic options
por: Mir, Tajamul H.
Publicado: (2022)

Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study
por: Ageno, Walter, et al.
Publicado: (2021)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
por: Innao, Vanessa, et al.
Publicado: (2022)

Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis
por: Kunutsor, Setor K., et al.
Publicado: (2020)

Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia
por: Hsu, Andrew, et al.
Publicado: (2020)

A thrombotic complication of COVID-19: cerebral ischaemia in the intensive care unit
por: Şahin, Ayça Sultan, et al.
Publicado: (2020)

Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation
por: Parry, Arshed Hussain, et al.
Publicado: (2020)

Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg
por: Pizzolo, Francesca, et al.
Publicado: (2020)

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
por: Beenen, L.F.M., et al.
Publicado: (2020)

Incidence of Thrombotic Events and Outcomes in COVID-19 Patients Admitted to Intensive Care Units
por: Avula, Akshay, et al.
Publicado: (2020)

More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism
por: van Dam, L.F., et al.
Publicado: (2020)

Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’
por: Hardy, M., et al.
Publicado: (2022)

Perioperative fatal thrombotic complication after elective meningioma resection in asymptomatic SARS-CoV-2 BA.5.2 (Omicron variant) infection
por: Lavinio, Andrea, et al.
Publicado: (2023)

Portal vein thrombosis in a patient with COVID-19
por: Franco-Moreno, A., et al.
Publicado: (2020)

Coronavirus disease 2019 is associated with catheter-related thrombosis in critically ill patients: A multicenter case-control study
por: Smit, Jasper M., et al.
Publicado: (2021)

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
por: Choi, Justin J., et al.
Publicado: (2020)

Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease
por: Ruzicka, Jan A.
Publicado: (2020)

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
por: van Haaps, Thijs F., et al.
Publicado: (2021)

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
por: Moll, Matthew, et al.
Publicado: (2021)

When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021)

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)

Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients
por: Speksnijder, Esther M., et al.
Publicado: (2022)

Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_754457l68m11513pr2mtgbr28c